Tag:
OncoMed Pharmaceuticals
Latest Headlines
Latest Headlines
OncoMed offers $115M IPO bet on cancer stem cell work
A year after scoring a $20 million milestone from Bayer, OncoMed Pharmaceuticals is preparing to see if it can generate enough excitement from investors for its cancer stem cell work to support a $115 million IPO.
Genomic Health, OncoMed to pursue companion diagnostics
Genomic Health and OncoMed Pharmaceuticals have an agreement to identify new biomarkers useful for future companion diagnostics that would go along with OncoMed's cancer drugs now in development.
OncoMed pockets $20M as it takes lead cancer antibody into trial
Redwood City, CA-based OncoMed hit an important milestone in its ambitious collaboration deal with Bayer Schering, earning a $20 million payday after the developer gained FDA acceptance for an IND
OncoMed scores big cancer development pact with Bayer
Germany's Bayer Schering is paying OncoMed $40 million upfront to partner on a slate of new drugs that target cancer stem cells. And the German pharma company is reserving an option to buy up to five
OncoMed banks an additional $93M in Series B
OncoMed Pharmaceuticals has added a cool $93 million to its Series B after completing the second tranche in the round. The new money brings the Redwood City, CA-based biotech's second round haul to
